UBS Group AG Boosts Position in Teleflex Incorporated (NYSE:TFX)

UBS Group AG raised its stake in shares of Teleflex Incorporated (NYSE:TFX – Get Rating) by 14.3% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 71,752 shares of the medical technology company’s stock after buying an additional 8,956 shares during the quarter. UBS Group AG owned about 0.15% of Teleflex worth $17,911,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Allspring Global Investments Holdings LLC lifted its position in Teleflex by 119.3% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 803,403 shares of the medical technology company’s stock worth $200,553,000 after buying an additional 437,083 shares during the last quarter. Eaton Vance Management lifted its position in Teleflex by 141.3% in the 1st quarter. Eaton Vance Management now owns 284,639 shares of the medical technology company’s stock worth $100,999,000 after buying an additional 166,682 shares during the last quarter. BNP Paribas Arbitrage SNC lifted its position in Teleflex by 219.6% in the third quarter. BNP Paribas Arbitrage SNC now owns 206,919 shares of the medical technology company’s stock valued at $41,686,000 after purchasing an additional 142,175 shares during the last quarter. First Manhattan Co. lifted its position in Teleflex by 20,440.4% in the third quarter. First Manhattan Co. now owns 111,945 shares of the medical technology company’s stock valued at $22,552,000 after purchasing an additional 111,400 shares during the last quarter. Finally, Vanguard Group Inc. lifted its position in Teleflex by 2.1% in the third quarter. Vanguard Group Inc. now owns 5,339,526 shares of the medical technology company’s stock valued at $1,075,700,000 after purchasing an additional 110,456 shares during the last quarter. Hedge funds and other institutional investors own 93.82% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on TFX. Mizuho boosted their target price on Teleflex from $220.00 to $250.00 in a research note on Tuesday, April 18th. Wolfe Research cut Teleflex from an “outperform” rating to a “peer perform” rating in a research note on Wednesday, April 26th. JMP Securities reissued a “market outperform” rating and set a $330.00 target price on shares of Teleflex in a research note on Thursday, March 30th. Raymond James boosted their target price on Teleflex from $231.00 to $259.00 and gave the company an “outperform” rating in a research note on Friday, February 24th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $291.00 price target on shares of Teleflex in a research note on Friday, February 24th. Six research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Teleflex has an average rating of “Moderate Buy” and an average target price of $271.75.

Teleflex Stock Down 0.6 %

NYSE TFX opened at $243.78 on Friday. The stock’s 50-day moving average price is $253.83 and its 200-day moving average price is $243.20. The company has a quick ratio of 1.41, a current ratio of 2.48 and a debt-to-equity ratio of 0.38. Teleflex Incorporated has a 52 week low of $182.65 and a 52 week high of $293.07. The company has a market capitalization of $11.43 billion, a P/E ratio of 31.78, a price-to-earnings-growth ratio of 2.61 and a beta of 1.00.

Teleflex (NYSE:TFX – Get Rating) last posted its quarterly earnings data on Thursday, May 4th. The medical technology company reported $3.09 EPS for the quarter, topping the consensus estimate of $2.97 by $0.12. Teleflex had a return on equity of 15.80% and a net margin of 12.68%. The firm had revenue of $710.90 million for the quarter, compared to the consensus estimate of $687.11 million. During the same quarter last year, the company earned $2.88 earnings per share. The business’s revenue for the quarter was up 10.8% compared to the same quarter last year. On average, equities research analysts predict that Teleflex Incorporated will post 13.29 earnings per share for the current year.

Teleflex Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 15th. Investors of record on Monday, May 15th will be given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 0.56%. The ex-dividend date of this dividend is Friday, May 12th. Teleflex’s dividend payout ratio is currently 17.73%.

Insider Buying and Selling

In related news, Director Stuart A. Randle sold 3,021 shares of the stock in a transaction dated Wednesday, May 10th. The stock was sold at an average price of $245.71, for a total transaction of $742,289.91. Following the completion of the sale, the director now owns 4,847 shares in the company, valued at $1,190,956.37. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 1.41% of the stock is currently owned by company insiders.

Teleflex Company Profile

(Get Rating)

Teleflex, Inc provides medical technology products which enables healthcare providers to improve patient outcomes and enhance patient and provider safety. The firm designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications.